Lazard Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.4M | Sell |
60,749
-9
| -0% | -$356 | ﹤0.01% | 953 |
|
2025
Q1 | $1.83M | Buy |
60,758
+54,201
| +827% | +$1.63M | ﹤0.01% | 998 |
|
2024
Q4 | $228K | Sell |
6,557
-16,366
| -71% | -$569K | ﹤0.01% | 1568 |
|
2024
Q3 | $917K | Buy |
22,923
+13,408
| +141% | +$536K | ﹤0.01% | 1111 |
|
2024
Q2 | $452K | Buy |
9,515
+1,660
| +21% | +$78.9K | ﹤0.01% | 1235 |
|
2024
Q1 | $339K | Buy |
7,855
+1,214
| +18% | +$52.4K | ﹤0.01% | 1147 |
|
2023
Q4 | $335K | Buy |
6,641
+84
| +1% | +$4.24K | ﹤0.01% | 1228 |
|
2023
Q3 | $296K | Buy |
6,557
+1,420
| +28% | +$64.1K | ﹤0.01% | 1271 |
|
2023
Q2 | $209K | Sell |
5,137
-1,051
| -17% | -$42.8K | ﹤0.01% | 1331 |
|
2023
Q1 | $220K | Buy |
6,188
+2,465
| +66% | +$87.6K | ﹤0.01% | 1283 |
|
2022
Q4 | $139K | Sell |
3,723
-322
| -8% | -$12K | ﹤0.01% | 1398 |
|
2022
Q3 | $178K | Sell |
4,045
-1,580
| -28% | -$69.5K | ﹤0.01% | 1294 |
|
2022
Q2 | $207K | Buy |
5,625
+568
| +11% | +$20.9K | ﹤0.01% | 1275 |
|
2022
Q1 | $186K | Sell |
5,057
-757
| -13% | -$27.8K | ﹤0.01% | 1269 |
|
2021
Q4 | $176K | Buy |
5,814
+4,554
| +361% | +$138K | ﹤0.01% | 1306 |
|
2021
Q3 | $42K | Sell |
1,260
-631
| -33% | -$21K | ﹤0.01% | 1767 |
|
2021
Q2 | $74K | Buy |
1,891
+1,854
| +5,011% | +$72.6K | ﹤0.01% | 1436 |
|
2021
Q1 | $1K | Sell |
37
-2,009
| -98% | -$54.3K | ﹤0.01% | 1825 |
|
2020
Q4 | $115K | Buy |
2,046
+872
| +74% | +$49K | ﹤0.01% | 1163 |
|
2020
Q3 | $55K | Sell |
1,174
-441
| -27% | -$20.7K | ﹤0.01% | 1158 |
|
2020
Q2 | $95K | Sell |
1,615
-1,024
| -39% | -$60.2K | ﹤0.01% | 1027 |
|
2020
Q1 | $124K | Sell |
2,639
-9,931
| -79% | -$467K | ﹤0.01% | 967 |
|
2019
Q4 | $759K | Buy |
+12,570
| New | +$759K | ﹤0.01% | 777 |
|
2016
Q4 | – | Sell |
-50,000
| Closed | -$1.83M | – | 1017 |
|
2016
Q3 | $1.83M | Buy |
+50,000
| New | +$1.83M | ﹤0.01% | 628 |
|